PRESENTATION

H1 FY2022 — Results presentation

H1 FY2022PDF · 72 pages6.5 MB
UNAUDITED
INTERIM RESULTS
for the six months ended 31 December 2021

-- 1 of 72 --

2
+2% new business API, including DH take-
on of new closed schemes and gross
revenue for Vitality Group
Core new
business
+6%
to R10 475m
Normalised
operating profit
+8%
to R4 872m
Normalised
headline earnings
+26%
to R2 876m
Headline
earnings
+78%
to R3 278m
GLOBAL

-- 2 of 72 --

3
USA
Discovery Insure	
Discovery Life	
Discovery Invest
Discovery Bank	
Discovery Health
Vitality Car	
Vitality Life	
Vitality Invest	
Vitality Health
HEALTH

-- 3 of 72 --

4
Three concurrent areas of focus
Navigating
COVID-19
Drive
for
growth
Robust
performance with
capital and
liquidity
strength

-- 4 of 72 --

Navigating COVID-19

-- 5 of 72 --

6
Most severe COVID-19 claims in period, but fourth wave was less
severe than previous waves
D614G Beta Delta Omicron
R538m
Discovery
Life COVID
claims
R3 940m
Discovery
Life COVID
claims
R1 871m
Discovery
Life COVID
claims
R115m
Discovery
Life COVID
claims
H1 2021 H1 2022
R698m R3 366m	R2 344m
Discovery Life
Gross COVID claims
Discovery Life
Gross COVID claims
Discovery Life
Gross COVID claims
H2 2021
R55m
Discovery Life
Gross COVID claims
H2 2020
Excess
deaths
Individual Life provisions
remain intact, expected to be
sufficient for H2 22 claims
80% IFRS provision
utilisation in H1 22
2,303 1,838
465
Provision at
30 June 2021
Utilisation Remaining
Provision at
31 December
2021

-- 6 of 72 --

7
12,584
19,042
19,956
23,437
0
500
1000
1500
2000
2500
3000
3500
0
4000
8000
12000
16000
20000
24000
05-Mar 25-Apr 14-Jun 03-Aug 22-Sep 11-Nov 31-Dec 19-Feb 10-Apr 30-May 19-Jul 07-Sep 27-Oct 16-Dec 04-Feb
7-day moving average of daily
admissions and deaths
7-day moving average of daily cases
Hospital Admissions Reported Cases
178
days
7-day moving average of new COVID-19 cases and hospital
admissions
172 93
Recurring pattern in the 4 South African COVID-19 waves to date
days between
peaks on average
days average length of wave
incl Delta (80 excl Delta)
Source of hospital admissions data: Lucille Blumberg, Richard Welch and Waasila Jassat – DATCOV, NICD
D614G Beta Delta Omicron
176
days
162
days
0%
2%
4%
6%
8%
10%
12%
Apr-20 Jul-20 Oct-20 Jan-21 Apr-21 Jul-21 Oct-21
Discovery Health clients case fatality
rate reducing over time
14 Day Average Case Fatality Rate: 1 April 2020-31 December 2021
Deaths as % of confirmed infections

-- 7 of 72 --

8
COVID-19 mutates in parallel – next variant hasn’t come from the last
Flu Measles
Mutates a lot to escape our
immunity. One major lineage,
and every few years, a new
variant sweeps and the others
go extinct
Virus mutates in a ladder-
like pattern, so fairly
predictable
Does not mutate to escape
immunity, more balanced
evolutionary tree
No immune pressure that
pushes one mutation to
outcompete another
Mutations haven’t evolved in a ladder-like
fashion - the next variant hasn’t been coming
from the last
COVID-19
Time Time
Selection
SOURCE: https://yourlocalepidemiologist.substack.com/p/predicting-the-next-booster
No selection

-- 8 of 72 --

9
Source: Centers of Disease Control and Prevention
https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e2.htm
Vaccination is important
Unvaccinated Pfizer 2-dose Pfizer 3-dose
70% 90%
Unvaccinated Pfizer 2-dose Pfizer 3-dose
92% 99%
Source: MedRxiv
https://ncrc.jhsph.edu/
Source: Discovery Health Analytics as at 19 February 2022
To be submitted for peer review and publication. Authors
have no conflicts of interest direct or in kind
Lower mortality risk	Lower
hospitalisation risk
Lower transmission
risk
Every 20% increase in
vaccination leads to 50%
reduction in positive tests for
unvaccinated people
Vaccine effectiveness was
retained through Omicron
Vaccines remain highly
effective at reducing mortality
* Includes all COVID-19 claims since the start
of the pandemic
Unvaccinated / Unknown
Partially Vaccinated
Fully Vaccinated
Historic Life COVID-19 claims*
by vaccination status:
Relative risk of severe illness
(Dec-Jan)
Risk of infection Deaths per 100,000 between Oct-Nov
Exposed to
unvaccinated
Exposed to
vaccinated
79%

-- 9 of 72 --

10
SA population has strong and increasing levels of immunity
Boosters and vaccination are essential, even after infection
70%-80% of population have immunity, but
it wanes due to reinfection risk*
*Reinfection rate of 20% for all waves except 55% for the Omicron wave. Actual COVID-19 deaths and the Verity IFR to determine the number of infections
0%
20%
40%
60%
80%
100%
20200201	
20200222	
20200314	
20200404	
20200425	
20200516	
20200606	
20200627	
20200718	
20200808	
20200829	
20200919	
20201010	
20201031	
20201121	
20201212	
20210102	
20210123	
20210213	
20210306	
20210327	
20210417	
20210508	
20210529	
20210619	
20210710	
20210731	
20210821	
20210911	
20211002	
20211023	
20211113	
20211204	
20211225	
20220115
% Infected
0%
20%
40%
60%
80%
100%
20200201	
20200222	
20200314	
20200404	
20200425	
20200516	
20200606	
20200627	
20200718	
20200808	
20200829	
20200919	
20201010	
20201031	
20201121	
20201212	
20210102	
20210123	
20210213	
20210306	
20210327	
20210417	
20210508	
20210529	
20210619	
20210710	
20210731	
20210821	
20210911	
20211002	
20211023	
20211113	
20211204	
20211225	
20220115
% Infected % Vaccinated % Vulnerable
c18% population vulnerable, but can
increase given immunity is not durable
Immunity from prior infection

-- 10 of 72 --

11
Encouraging COVID-19 trends, provisions remain intact to cover best
estimate scenario
At least partially
vaccinated Fully
vaccinated
over age 60	Total
lives
Members
over age
60
Health 49% 81% 72%
Individual
Life* 75% 82% 75%
Group Life* 78% 88% 82%
Higher risk Discovery
population vaccinated
Actual % vaccinated
*Sum assured weighted
Individual Life provisions remain
intact, expected to be sufficient
for H2 22 claims
80% IFRS provision
utilisation in H1 22
2,303 1,838
465
Provision at
30 June 2021
Utilisation Remaining
Provision at
31 December
2021
Case fatality rates reduced
significantly
1 3 5 7 9 11 13 15 17 19 21 23 25 27
Weeks
1st Wave 2nd Wave
3rd Wave 4th Wave
Life deaths

-- 11 of 72 --

Financial results

-- 12 of 72 --

13
Health 1 750 +5% 3 598 +29%
Life 1 934 +1% 1 267 +9%
Invest 517 +10% 1 519 +15%
Insure 15 -86% 597 -3%
Vitality Health 850 +39% 708 +11%
Vitality Life 361 +10% 554 -1%
Vitality Group 234 -2% 668 +7%
Ping An Health 140 +25% 1 426 -21%
Bank (498) -18% >200k
New-to-Bank
clients
+151%
Other New (470) +21% 772 -23%
+6%
Core new business API
R10.5bn
+8%
Operating profit
R4.9bn
Resilient performance
Resilient financial performance, supported by continued operational efficiency and new
business over the period
Strong positive experience variances with robust capital and liquidity positions. R6bn gross
COVID-19 claims paid cumulatively, reduced asset base returns impacting earnings
Robust performance with strong increase in new business growth and assets under
management
Difficult period, characterised by an increased loss ratio driven by adverse weather events
combined with motor parts inflation dramatically exceeding CPI
Excellent operating performance driven by sustained membership growth, rigorous
expense controls and excellent care management
Robust performance as a result of management actions taken over previous reporting
periods. Made significant progress with Prudential in agreeing the terms of a long-term
deferral of the Part VII transfer
Strong underlying growth, with growth in profit from operations impacted by foreign
exchange gains in the prior period not being repeated
Robust profit growth. New business written premium reduced due to rebasing co-
operation with Ping An Life for business written in certain regions in China
Operating loss reducing faster than plan due to excellent performance across all metrics.
Benefits of the business model continue to manifest in improving operating leverage
8% of Group operating profit on new (excl bank) vs 7% in the prior period. Half of spend
relates to Vitality Group with a notable increase in globalising Discovery’s Vitality and
Health capabilities via Vitality Health International
ZARm

-- 13 of 72 --

14
-
1,000
2,000
3,000
4,000
5,000
H1
2014
H1
2015
H1
2016
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
Maintaining excellent growth
Operating profit (Rm)
+8%
Core new business (Rm)
-
2,000
4,000
6,000
8,000
10,000
12,000
H1
2014
H1
2015
H1
2016
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
+6%

-- 14 of 72 --

15
Businesses better off than pre-COVID-19
Life insurance	Health insurance
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
to R1 750m
+5%
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
to R1 934m
+1%
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
+10%
to R517m
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
to R15m
-86%
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
to £41.5m
+44% +25%
to R140m
+7%
to $15.5m
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
to £17.6m
+15%
to R1 267m
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
+9%
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
to R3 598m
+29%
Excl new closed schemes
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
+15%
to R1 519m
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
to R597m
-3%
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
+15%
to £34.5m
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
+3%
to £27.1m
+16%
to $44.5m
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
-21%
to R5.7bn*
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
Operating profit
New business
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022
*100% PAH
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022

-- 15 of 72 --

16
-
1,000
2,000
3,000
4,000
5,000
6,000
H1 2018 H1 2019 H1 2020 H1 2021 H1 2022
-
50
100
150
200
250
H1 2018 H1 2019 H1 2020 H1 2021 H1 2022
Investing heavily offshore, strong operating profit in the strands
16%	18%	18%	8% 52%	42%	52%	41%
% in New x%
Operating profit (ZARm):
4% 47%
-11%
+135%
+36%
-
200
400
600
800
1,000
1,200
H1 2018 H1 2019 H1 2020 H1 2021 H1 2022
-
1,000
2,000
3,000
4,000
H1 2018 H1 2019 H1 2020 H1 2021 H1 2022
+4%
+5%
+2%
-5%
+72%
8%	9%	33%	31%	17%
+30%
+110%
-21%
+0%
71% Bank and Vitality Group
Bank
Other SA
UK
VG
51%
18%
11%
20%
17%	18%	21%	13%	6%
+8%
+19%
+0%	-4%
Total Group:

-- 16 of 72 --

17
21%
22%
23%
24%
25%
26%
27%
28%
29%
FY
2020
H1
2021
FY
2021
H1
2022
Group is well capitalised and highly liquid
Dec 20
Cover
Dec 21
Cover
Life 1.8x 1.8x
Insure 1.8x 1.8x
VH 2.0x 1.9x
VL 2.0x 2.2x
Bank1 1.3x 1.4x
PAH2 2.1x 2.1x
1 Capital Adequacy Ratio
2 Before capital injection
3 Considers SA Liquidity and liquid excess assets for Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank
4 SA cash + undrawn committed facilities
SA Liquidity4 , R millions	FLR R millions
Liquid excess assets above minimum
regulatory capital requirements
Strongly capitalised FLR is within target
Highly liquid across
the Group3
Sufficient liquidity
at the centre
DHMS solvency
(unaudited) 38.6%
23.9%
-
4 000
8 000
12 000
16 000
FY
2020
H1
2021
FY
2021
H1
2022
-
500
1 000
1 500
2 000
2 500
FY
2020
H1
2021
FY
2021
H1
2022
28%

-- 17 of 72 --

18
Annualised ROEV
14% excluding COVID-19,
forex and economic changes
Opening EV Value of new
business
Unwind of
discount rate
Non-economic
experience
variances and
methodology &
assumption
changes
Operational EV Economic
experience
variances and
methodology &
assumption
changes
Forex Finance costs Other Change in
capital and
dividends
Closing EV
+22.7%
Group Embedded Value
R82 920m
R80 895m
R74 645m
Operational EV Economic and other
+17%
Annualised ROEV

-- 18 of 72 --

19
Reported profit for period affected by three key factors
Rm
6 months ended
Dec 2021
6 months ended
Dec 2020 %
Normalised profit from operations 4,872 4,507 +8%
Economic assumptions adjustment - DL 498 -493
Economic assumptions adjustment - VL -46 1
Finance charges excl. 1DP finance lease -698 -649
Unrealised gains/(losses) on foreign exchange contracts not designated as a hedge 99 -207
Foreign exchange gains/(losses) 128 -362
Deferral fees related to Prudential Book transfer -92 -96
Investment income and fair value remeasurements 134 149
Vaccination costs -137 -
Other -49 -231
Profit before tax 4,709 2,619 +80%
Tax -1,404 -744
Profit attributable to preference shareholders -28 -34
Profit attributable to equity holders 3,277 1,841 +78%
Headline adjusting items 1 1
Headline earnings 3,278 1,842 +78%
Economic assumptions adjustment (DL and VL) -321 354
Other normalisation adjustments -81 88
Normalised headline earnings 2,876 2,284 +26%
1
2
3
1
2
3
In SA, significant drop in real
interest rates
In UK, derivatives highly
effective in mitigating
volatility, convexity costs of
GBP2.2m
Extreme volatility in Rand
with significant weakening of
the Rand compared to a
strengthening in the prior
period
Continued investment in
supporting the national
vaccination campaign in SA
Due to the continued uncertainty
caused by COVID-19 on the
demographic and economic
environment in SA, the Discovery Board
has decided to retain its prior stated
position during the pandemic and has
decided not to declare an ordinary
interim dividend for the period ended
31 December 2021. The reintroduction
of an ordinary interim dividend will be
considered on an ongoing basis

-- 19 of 72 --

The Vitality shared-value
model

-- 20 of 72 --

21
The three trends remain relevant
NATURE
OF RISK TECHNOLOGY
SOCIAL
RESPONSIBILITY
Standard risk factors, behavioural risk
factors, correlations, pricing precision
Digital functionality, engagement,
behaviour change, personalisation
Make people healthier, good for society,
good for the planet
HEALTH MONEY	DRIVE

-- 21 of 72 --

22
Conviction in the model
PREDICTION
TECHNOLOGY
ENGAGEMENT AND
INTERVENTION
HEALTH INSURANCE
TECHNOLOGY AND
INTELLIGENCE
PRODUCT
DATA
Know Your
Health
Improve Your
Health
Get
Rewarded> >
Healthy Futures
State of the art health
assessment framework
Assessment
Healthspan calculation
engine
GateWay
Connectivity enabler
connecting devices, wellness
and health providers and
rewards
Vitality Data Exchange
Vitality Data Portal
SDK
Partner Classification
Adherence API
Next
Best
Action
Next Best Action
Leading health
recommendation engine
Lifestyle Goals
Promotions
Notifications
Quizzes
Content Manager
Signature Experiences
Vitality Points
Vitality Status
Incentives and
rewards
Prediction Engagement Shared-value

-- 22 of 72 --

23
Risk prediction with Healthy Futures

-- 23 of 72 --

24
Example

-- 24 of 72 --

25
Next
Best
Action
MEMBER
DATA
HEALTHSPAN
 
CASUAL
INFERENCE
Demographics
Engagement history
Health claims
Life claims
Preferences
∆qx │ ∆behaviour
Quit smoking
Lose weight
Manage stress
& burn-out
Become active
Increase level of
physical activity
Quit smoking experience
12 weeks
Healthy weight experience
12 weeks
Be well experience
6 weeks
Get active experience
6 weeks
Weekly
Coaches
Coaches
“Try this activity
next week”
+10
points
PREDICT RECOMMEND INCENTIVISE
Cycle is repeated

-- 25 of 72 --

Execution in the three
strategic strands

-- 26 of 72 --

27
1
2
3
The strategic strands
Perfect composite model, #1 in every industry, and the Bank pivoting to growth as the composite-maker within SA
Best-in-breed products across businesses and operating as a fully integrated composite business with a seamless
One Vitality client journey. A successful entry into motor insurance
Leading wellness and healthcare platform that provides preeminent life and health insurers globally with our
Vitality shared-value and health management capabilities to assist them in making their customers healthier, while
ensuring their products are more competitive with better margins
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health	
Vitality Health	
Vitality Car	
Vitality Life	
Vitality Invest
USA
HEALTH

-- 27 of 72 --

28
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health
Excellent performance across all metrics,
performance exceeded expectations resulting in the
Bank’s operating loss reducing faster than plan

-- 28 of 72 --

29
Key focus areas for the Bank
Full service
bank at scale
Shared-value
banking model
Vitality Money
Digital Bank
scalability
1
2
3
Transaction and
credit cards
Demand, tax-free, notice
& fixed-deposit accounts
(24hr – 5 years)
Multi-currency
accounts
Vitality Money Financial
Analyser
5 key financial
behaviours
Dynamic interest
rates
Dynamic, deep
discounts
Shared-value
rewards currency
4.4%
8.5%
Savings Lending
Virtual
cards
Electronic
KYC Live Assist	Mobile 	Web 	Virtual
cards
Electronic
KYC Live Assist	Mobile 	Web
<5min onboarding Operating leverage
24/7/365
availability
Strong returns
2021 	2022 	2023 	2024 	2025 	2026
Base 	Upside 	Current
Market-leading app
functionality

-- 29 of 72 --

30
Discovery Bank’s key performance metrics trending positively
Total clients Total accounts Retail deposits Advances Operating result
>400k >850k R9.5bn R4.2bn -R498m
Q1
FY21
Q2
FY21
Q3
FY21
Q4
FY21
Q1
FY22
Q2
FY22
Bin - Not Upgraded
Bin - Upgraded
New to Bank
Q1
FY21
Q2
FY21
Q3
FY21
Q4
FY21
Q1
FY22
Q2
FY22
Q1
FY21
Q2
FY21
Q3
FY21
Q4
FY21
Q1
FY22
Q2
FY22
Q1
FY21
Q2
FY21
Q3
FY21
Q4
FY21
Q1
FY22
Q2
FY22
Headline figures as at February 2022
H1
FY18*
H1
FY19*
H1
FY20
H1
FY21
H1
FY22
*Includes capital development costs
during build phase

-- 30 of 72 --

31
Growth of 750+ high quality clients per day
New business
composition
Average daily
new business
Channel mix Product mix
~750 average daily sales; highest
new business levels across
the SA Composite
0
100
200
300
400
500
600
700
800
Life (Excluding standalone products)*
Invest*
Insure*
Health (Individual)*
Bank
* Average daily new business from July 2021 to Jan 2022
Healthy distribution of “Discovery”
and “new-to-Discovery” clients
30%
14%
7%
3%
46%
1 Product
2 Products
3 Products
4+ Products
New to Discovery
0%
20%
40%
60%
80%
100%
Jan-21	
Feb-21	
Mar-21	
Apr-21	
May-21	
Jun-21	
Jul-21
Aug-21	
Sep-21	
Oct-21	
Nov-21	
Dec-21
Self-assisted Connect
Intermediated
Diversified channels – traction in
intermediated channel
0%
20%
40%
60%
80%
100%
Dec '20 Dec '21
Savings only Trans PAYT
Trans Bundle Credit & Suite
±50% Credit and Transaction
Bundled sales

-- 31 of 72 --

32
Market-leading NIR per client with strong engagement
Engagement mix Gross NIR pcpm (DSY v market)	Spend
31% Growth in spend y-o-y 34% Primary and highly active clients
34%
47%
20%
Primary and highly active Active Inactive
• Primary and highly active – ≥15% of net income as spend – for
primary clients, salary deposits/ equivalent inflow
• Active – <15% of net income as spend
• Inactive – No activity or not in good standing
DSY
>12m
Bank 1 Bank 2 DSY Big 4
average
(excl
DSY)
Bank 3 DSY
<12m
Bank 4
16% Higher than Big 4 average
+16%

-- 32 of 72 --

33
Increasing market share of high-quality advances book
Credit card market
share
Average advances Credit loss ratio Net interest
margin
Total NII
0%
4%
8%
12%
16%
20%
DSY market share 2021
DSY market share Oct -Nov
±20% Market share in >R100k
pm income band
#1 Card volume in
high-net-worth
segment*
*Signature and Infinite VISA card volume
R4.2bn
Q1
FY21
Q2
FY21
Q3
FY21
Q4
FY21
Q1
FY22
Q2
FY22
J
0%
1%
2%
3%
4%
5%
6%
7%
8%
Q1
FY1
Q2
FY21
Q3
FY21
Q4
FY21
Q1
FY22
Q2
FY22
J
80%
90%
100%
110%
Q2
FY21
Q3
FY21
Q4
FY21
Q1
FY22
Q2
FY22
J
Cost of funds
Net interest margin
Indexed to Q2 FY21; Q1 FY21 excluded due to
billing anomalies during the BIN migrations
Q2
FY21
Q3
FY21
Q4
FY21
Q1
FY22
Q2
FY22
Indexed to Q2 FY21

-- 33 of 72 --

34
Shared-value model correlations driving positive client and financial
outcomes
4.4%
* Bronze lapse rate higher than Blue as these clients had some engagement and so are more willing to phone the call centre to close their account vs leaving account idle
Funding
1 2 11
64
Blue Bronze Silver Gold and
Diamond
Average deposits
7x
higher average
deposit
Gold and Diamond
vs Book average
Revenue
1.0 1.7
2.6
4.0
Blue Bronze Silver Gold and
Diamond
Spend
4x
higher spend
Gold and Diamond vs Blue
Indexed to Blue	Indexed to Blue
Advances
100%
Blue Bronze Silver Gold and
Diamond
Arrears rate by VM status
96%
lower arrears rate
Gold and Diamond vs Blue
Vitality Money
correlations
transcend
income bands
100%
Gold Platinum Black Purple
Arrears rate by product colour

-- 34 of 72 --

35
Digital scalability driving 40% positive operating leverage
Revenue vs expense growth indexed to Jan 21
50%
60%
70%
80%
90%
100%
110%
120%
Gross NIR pcpm Expenses per account
* As at Feb 2022; Other banks include FNB, ABSA, Nedbank and Standard Bank
Revenue per client
Expenses per client
Expenses Clients
H1 FY21
H1 FY22
+2.5% +35%
Spend/client Fees/client
H1 FY21
H1 FY22
+9% +2%
40%

-- 35 of 72 --

36
Discovery Bank tracking ahead of upside scenarios to deliver attractive
returns and profitability
2021 2022 2023 2024 2025 2026
Base Upside Current
Business case sensitivities and scenarios
• In addition to the above assumptions, the financials are sensitive to other factors such as the CLR, marketing spend,
advances trajectory, deposits trajectory, cost of funds, regulatory capital requirements, inflation etc.
• These sensitivities illustrates the pattern of profit emergence to breakeven and are not intended to be a forecast. Forward
looking information on this slide is for illustration purposes and has not been reviewed or reported on by the auditors
Key financial levers
Average advances pc
(Rands)
Average gross NIR
pcpm
(growth; %, before rewards and expenses,
long-term assumptions represent a CAGR
between FY22 and FY26)
Expenses growth
(%, excl. depreciation/ amortization,
Long-term assumptions represent a
CAGR between FY22 and FY26)
Model efficacy: CLR
(%)
Growth: clients
(average daily new business)
0%
5%
10%
Current Base Upside
5
10
15
Current Base Upside
0%
2%
4%
Current Base Upside
0%
4%
8%
12%
Current Base Upside
0
500
1,000
Current Base Upside
Long-term economics (FY26)

-- 36 of 72 --

37
Key focus areas for the Bank
Full service
bank at scale
Shared-value
banking model
Vitality Money
Digital Bank
scalability
1
2
3
Transaction and
credit cards
Demand, tax-free, notice
& fixed-deposit accounts
(24hr – 5 years)
Multi-currency
accounts
Vitality Money Financial
Analyser
5 key financial
behaviours
Dynamic interest
rates
Dynamic, deep
discounts
Shared-value
rewards currency
4.…	
8.…
Savings Lending
Virtual
cards
Electronic
KYC Live Assist	Mobile 	Web 	Virtual
cards
Electronic
KYC Live Assist	Mobile 	Web	
<5min
onboarding
Operating
leverage
24/7/365
availability
Strong returns
2021 	2022 	2023 	2024 	2025 	2026
Base 	Upside 	Current
Market-leading
app functionality
Composite
maker
4 …

-- 37 of 72 --

38
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health
Performed robustly across all metrics with
strong new business growth

-- 38 of 72 --

39
Discovery Health
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
Normalised operating profit New business Membership
Excluding the take-on of
new closed schemes
1993
1995
1997
1999
2001
2003
2005
2007
2009
2011
2013
2015
2017
2019
2021
DHMS
Restricted Schemes
Non Scheme Products
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
to R1 750m to R3 598m
+5% +29% lives under administration
>3.7m

-- 39 of 72 --

40
0%
2%
4%
6%
8%
10%
12%
2013 2014 2015 2016 2017 2018 2019 2020 2021
Lapse rates
5.1%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
H1
2013
H1
2014
H1
2015
H1
2016
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
No movements Upgrades Downgrades
Discovery Health Medical Scheme performance summary
Membership and growth Plan stability and low lapses Security and surplus
1993	
1995	
1997	
1999	
2001	
2003	
2005	
2007	
2009	
2011	
2013	
2015	
2017	
2019	
2021
Plan movements
lives
>2.78m
market share
57.5%
credit rating
AAA
unaudited solvency
38.6%
0.45% increase
following strong new business
in a contracting market
Stable and resilient membership base that is inelastic to
economic shifts and changes in the healthcare environment
unaudited reserves
R30.8bn
-
5
10
15
20
25
30
2003
2005
2007
2009
2011
2013
2015
2017
2019
2021
R billion

-- 40 of 72 --

41
0%
50%
100%
150%
200%
250%
2019 2021
Continued excellence in the closed scheme market
1997	
1999	
2001	
2003	
2005	
2007	
2009	
2011	
2013	
2015	
2017	
2019	
2021
18
700k
32%closed scheme
market share
closed schemes
lives
Robust growth Consistent, stable performance across all closed schemes
25% Solvency requirement
450%
500%
0%
2%
4%
6%
8%
10%
12%
2019 2021 Average medical inflation
Solvency
Contribution increases

-- 41 of 72 --

42
Jan-20
Apr-20
Jul-20
Oct-20
Jan-21
Apr-21
Jul-21
Oct-21
In Hospital Utilisation
Out of Hospital Utilisation - Risk
13%
11%
10%
2%
11%
9%
10%
12%
Cardio Musc-ske Tumours Infections
2019 2021
Key healthcare insights emerging in 2022
Healthcare utilisation is
increasing following drop
Population health has
worsened
COVID-19 has increased
overall disease burden
COVID-19 will continue
to feature prominently
COVID-19 expected to add R7bn to
overall expenditure in 2022, in line
with 2021
3.6%
1.6%
1.2%
1.5%
5.0%
1.8%
1.5%
5.0%
Diabetes HIV Cancer Mental
Health
Pre-COVID-19 During COVID-19
Percentage of lives with key health
issues
Percentage of claims attributed to
selected key healthcare drivers
Hospital
admissions
Vaccines PCR Testing
Current Cost Future Expected Cost
+10% + R1 440m
– R1 027 m
– R462m
2019 level
High utilisation end of 21
indicative of what to expect in 22
2020 2021
COVID-19 showing initial signs of
impacting overall morbidity
1.5x
higher risk of
developing
Diabetes post
COVID
2.75x
higher risk of
developing a cardiac
condition post COVID

-- 42 of 72 --

43
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health
Strong positive experience variances with robust capital and liquidity
positions. R6bn gross COVID-19 claims paid cumulatively which
reduced asset base returns and impacting earnings

-- 43 of 72 --

44
Discovery Life
Record high claims
paid, 3rd and 4th
COVID-19 waves in
this period
Normalised
operating profit
Strong capital
and liquidity
New business API
184%
H1 2022
3,403
H1 2022
125%
SCR target 1xILT
SCR
coverage
Liquidity
coverage
to R1 267m
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
+9%
Positive cashflow
from existing book
impacted by in period
COVID-19 claims
698
2,344
3,366
6,408
H1
2021
H2
2021
H1
2022
Total
Gross claims (Rm)
Excess cash payments
towards COVID-19 claims
impacts on the NRR unwind,
reducing earnings by cR261m
(13%) in the HY period
-29
2,126
640
1.42x Liquidity cover
implies a large liquidity
buffer of R3.4bn relative
to the net cashflow of
-R29m over the period
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
to R1 934m
+1%
Cashflows
from
existing
business
NB
Strain
and Net
FinRe
Net
Cashflow
excl
COVID-19
COVID-19
Impact*
Net
Cashflow
after
COVID-19
Life and Invest cashflow (Rm)
*Net of additional financing

-- 44 of 72 --

45
Robust embedded value growth driven by positive operating variances
and inforce growth, resilient new business margins
to R38.1bn
Life and Invest embedded value
(Rbn)
+10%
Value of new business and margin
VNB (Rm) Life: Annualised VNB
margin (%) Life:
Margin improvement vs. June 21:
• COVID-19 provision unwind
• Pricing and product initiatives
• Focus on quality over quantity of new business
• Expense controls
June 2021
New business
Expected unwind incl New
Business
Experience Variances
Methodology and
Assumption Changes
Total before Economic
Impact
Experience Variances
Methodology and
Assumption Changes
Components below the line
December 2021
34.8bn
37.3bn
38.1bn	Economic	Non-economic 291
120
227
H1
2021
H2
2021
H1
2022
8.2%
5.70%
6.8%
H1
2021
FY
2021
H1
2022
+20%
Positive non-
economic experience
variances
Annualised ROEV
before economic
impact
+15%	H1 2022 (Rm)
286
Lapses and surrenders	
Mortality and morbidity
Premium and fee income
Policy alterations
Other
Total

-- 45 of 72 --

46
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health
Robust performance with strong increase in new business growth
and assets under management

-- 46 of 72 --

47
H1 2020 H1 2021 H1 2022	H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
Discovery Invest
Normalised
operating profit
New business Assets under
administration
Lapse rates Shared value
outcomes
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022 2018 2019 2020 2021 2022
H1 H1 H1 H1 H1
+10% +15% -16%
to R517m to R1 519m
+19%to R128bn
lower drawdowns
12%
more years to
retirement
7.5
in shared value
benefits accrued
and paid to clients
R13bn
Since the launch of shared
value:

-- 47 of 72 --

48
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health
Difficult period, characterised by an increased loss ratio driven by
adverse weather events combined with motor parts inflation
dramatically exceeding CPI

-- 48 of 72 --

49
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
Discovery Insure
New business	Gross written
premium
to R2 318m1 to R597m1
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
1 Personal lines figures only
2 CMT is in the building phase and the decrease in CMT profitability in 2021 and 2022 is due to the acquisition of TrueMotion and associated costs
-3%	+13%
Market share
in GWP
Personal Lines only. Assumes 6% in GWP
market growth since 2018
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
7%
Vehicles insured
+11%
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
to 292 0001
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
CMT Personal lines
Normalised
operating profit
to R15m2
-86%

-- 49 of 72 --

50
51%
53%
55%
57%
59%
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
0.0%
0.5%
1.0%
1.5%
2.0%
2.5%
Blue Bronze Silver Gold and
diamond
Improved quality of drivers but external factors affected claims
Improved loss ratios
with client duration
Loss ratio by duration H1 2022
0%
25%
50%
75%
100%
0 1 2+
0
20
40
60
80
100
Blue
Bronze
Silver	
Gold
Diamond
Better risks from gold
and diamond drivers
-48%
Lower loss
ratios than
Blue
Relative loss ratios by Vitality
Drive status
Retention of good
drivers
Lapse rates by Vitality status
-73%
Lower lapses
compared to
Blue clients
H1 2022 loss ratio
higher than 2021
Loss ratios H1 2018 – H1 2022
+3%
High car
parts
inflation
+1%
Hailstorms
+1%
Fire claims
+1%
Power surge
-2%
Other

-- 50 of 72 --

51
Economic and environmental factors contributed to a higher loss ratio
High inflation1 in the
cost of car parts
Resulting from rapidly
increasing shipping costs
Impact with value of
car makers
Car makers by value insured
TOYOTA
13%
MERCEDES-
BENZ
11%
VOLKSWAGEN
11%
BMW
10%
FORD
10%
LAND
ROVER
5%
AUDI
5%
HYUNDAI
5%
NISSAN
3%
MAZDA
3%
KIA
3%
PORSCHE
3%
RENAULT
2%
HONDA
2%
SUZUKI
2%
OTHER
14%
Car parts inflation by car
different car makers
Average car
parts inflation
in 2020
16.90%
16.90%
14.10%
12.50%
10.40%
-10% 0% 10% 20%
Car brand A
Car brand B
Car brand C
Car brand D
Car brand E
Car brand F
Car brand G
Car brand H
Car brand I
Car brand J
2020
2021
Average car
parts inflation
in 2021
13.2%	3.2%
Jul-19
Oct-19	
Jan-20	
Apr-20	
Jul-20
Oct-20	
Jan-21	
Apr-21	
Jul-21
Oct-21
Global container freight rate index
from July 2019 to January 20222
10% - 15%
1 inflation based on initial costing
2 https://www.statista.com/statistics/1250636/global-container-freight-index/
High repair cost
inflation, hailstorms
and fire claims
Reasons for variations in AvE
claims
Hailstorms
Fire
claims
Power
surge High motor repair
cost inflation
Total variation in actual
vs expected claims
Other
Once-off
Recurring
19%
11%
7%
43%
18% 4X
X 500%
increase in cost of car parts
due to increase in shipping
costs

-- 51 of 72 --

52
Vitality Health	
Vitality Car	
Vitality Life	
Vitality Invest

-- 52 of 72 --

53
Lives covered
UK Composite
Normalised
operating profit
Earned premiums New business
GBP millions	
GBP millions	
GBP millions
Vitality Health
Vitality Car	
Vitality Life	
Vitality Invest
Best-in-breed products
across businesses and
operating as a fully
integrated composite
business with a seamless
One Vitality client journey
to £438m	to £54.2m
+36% +7% +11% +7%
to £77.2m	to 1.48m lives
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022

-- 53 of 72 --

54
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
Vitality Health
Normalised
operating profit
Earned premiums Lives covered New business
GBP millions	
GBP millions	
GBP millions
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
to £274m	to £41.5m
+44% +7% +10% +15%
to £34.5m	to 764k lives

-- 54 of 72 --

55
Strong performance across all metrics driving strong profit growth
Excellent performance of
retention strategy
100
82
84
82 81
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
Lapse rates
100
91
86
88
80
H1
2017
H1
2018
H1
2019
H1
2020
H1
2022
Per life per month expenses
Further improvement in
expense efficiencies
High impact of pricing
initiatives over time
Focus on Renewal
pricing and Lapse
modelling
New business pricing
sophistication
New business as a % of lives insured
Lapses as a % of lives insured
H1
2017
H1
2019
H1
2022
154k
Lives added
68k
Lives added
8%
9%
4.2%

-- 55 of 72 --

56
Strategically positioned to accommodate a catch-up in claims post-
COVID-19
Authorisations have returned to
pre-COVID-19 levels
Widening access to care through digital pathways has improved
efficiency of care delivery
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
Cardiac Musculoskeletal Oncology
Psychiatry Total 0%
10%
20%
30%
40%
2015 2016 2017 2018 2019 2020 2021
Vitality GP Talking Therapies Physiotherapy
2015 2017 2019 2021
2015 2016 2017 2018 2019 2020 2021
Talking Therapies Total Claims
2020 2021
Primary care now accounts for over 40% of
all claims, up from less than 10% in 2015
Physiotherapy volumes have increased, with digital
pathways now accounting for ~60% of claims
Talking Therapies has grown to represent over 80%
of all mental health claims
Digital Offline
% of Claims on Primary care
Volume of mental
health claims
Monthly authorisations per 1000 lives
Hip replacement Knee replacement
Before network After network
Expansion of premier consultant network has
improved claims cost efficiencies
-10% -11%
Over 100k virtual
consultations in 2021

-- 56 of 72 --

57
Vitality Life
Normalised operating
profit
Earned premiums Lives covered New business
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
to £164m
+7% +6%
to 686k lives
GBP millions	
GBP millions	
GBP millions
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
to £17.6m
+15% +3%
to £27.1m
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022

-- 57 of 72 --

58
0%
20%
40%
60%
80%
100%
120%
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
Expected
Positive trend in lapse
AvE continued
Continued strong operating performance driven by excellent
retention strategy
Benefits from addressing 10
point plan now being
witnessed
Intervened against ‘high lapse’ brokers
Restructured franchise channel
Consolidated ops and service at Group
level
Enhanced retention capabilities
Strengthened actuarial bases and set
up COVID-19 provisions
Entered into interest rate hedge
Deferred Part VII transfer
Changed Group legal entity structure
Adapted elements of actuarial
methodology
Sourced liquidity funding in the UK
Area Management actions
1
2
3
4
5
6
7
8
9
10
OPERATIONS
CAPITAL
LIQUIDITY
0.7
0.9
1.1
1.3
1.5
Hedge performed well in a volatile interest
rate environment
Improving swap rates have increased the intrinsic value of the swaption
Swaption in
the money
-30
-20
-10
0
10
20
30
01-Jul-21 01-Aug-21 01-Sep-21 01-Oct-21 01-Nov-21 01-Dec-21
Liability P/L Net P/L Swap P/L
GBP Millions

-- 58 of 72 --

59
USA
HEALTH

-- 59 of 72 --

60
Strong underlying growth. Broadening our global
impact through a health insurtech JV in Asia with AIA
Vitality Health
International
Insurance
Partner Markets
USA
HEALTH

-- 60 of 72 --

61
Vitality Group
1 All insurance partnerships excluding equity investments
2 Excludes services related to system implementation and other cost recoveries and rewards
Revenue Operating result
to $44.5m
R667.5m
Integrated API by
insurance partners
Insurance partners
membership
to $766m
R11.5bn
to $15.5m
R234m
to 2.7m
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022 H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
Insurance Partners Vitality USA
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
1
2
+26%
+45%
Gains from Foreign Exchange Contract
taken out during COVID period

-- 61 of 72 --

62
Insurance Partner Markets

-- 62 of 72 --

63
-
20
40
60
80
100
120
2019 2020 2021 2022 2023 2024 2025 2026
$ million
Revenue Expenses Margin
27% 67%
New market
Old market
9
46
157
Insurance Partner Markets
Continued robust performance as the platform scales
Margin emergence
Insurance markets revenue & expenses
Actual → Forecasted
60%
*
• H1 is based on actuals. H2 is based on forecast.
• Forecast information is indicative only and has not been audited or reviewed”
38%
Guaranteed revenue
Strong intrinsic contract
values
KPIs
Number of
markets
Penetration
rates
Engagement
Integrated
products
API &
Members
2016 2021	2017 2018 2019 2020
28
2017 2018 2019 2020 2021
Present value of existing contract revenues

-- 63 of 72 --

64
Shared-value health insurance approach
Unique ecosystem
Vitality Health International
Broadening our global impact
Vitality Health
International
USA
HEALTH

-- 64 of 72 --

65
Extending the behavioural platform through a health insurtech JV in
Asia with AIA
Capital-light and technology-centric insurtech business
Improves clients’ underlying performance & shares in the
value created
• Proprietary IP and native
strength of digital assets and
programs
• 250 Discovery talent,
including senior
management
• Global innovator in health
insurance with success in
both developed and
emerging markets
• 30 years of experience and
execution track record
• Providing initial capital
• Leading pan-Asian health
businesses, with a captive
base of ~50m clients across
9 key geographies
• Deep understanding and
networks in Asia and a
trusted brand with high
recognition
• 100+ years experience with
execution track record and
medical expertise
75% 25% equity stake, a series of IP
and performance fees and a
material relief from capital
equity stake

-- 65 of 72 --

66
Offering a full suite of services to healthcare businesses
Claims & Core
Operations
Value-based
networks
Medical cost
optimisation
Digital
engagement
Data and
analytics
Insurance
Propositions
Products
Market
segments
Existing AIA
health
businesses Corporates
Private and
public providers
Pharma/
Medtech
DATA ANALYTICS & HEALTH INTELLIGENCE
HEALTH INSURANCE TECHNOLOGY
PRODUCT ARCHITECTURE
VIRTUAL CARE AND PROVIDER NETWORKS
CLAIMS &
ADMINISTRATION
DIGITAL HEALTH
ECOSYSTEM
CLAIMS
ANALYSIS
SEGMENTATION &
PROFILING
VALUE-BASED CARE
PRIMARY CARE HOSPITAL
CARE
CRITICAL
ILLNESS
CARE DELIVERY NETWORKS	Capabilities
Private and
public payors

-- 66 of 72 --

67
Year 0 Year 1 Year 2 Year 3 Year 4 Year 5
Claims reduction
Significant value to be unlocked in an enormous market
Amplify Health has already proven potential
through a POC
Potential to scale in rapidly-expanding digital
healthcare space in Asia
Insurance Market A| Medical Cost Optimisation (Fraud, Waste & Abuse)
FWA Capability Development
claims savings in 5-year period
2020 healthcare expenditure in markets where
AIA operate
Annual growth in Asia health expenditure
(vs 5% in developed markets)
AIA
Markets
Individual policies
Group insurance scheme members
(AIA only)
Pharma/
Medtech Expenditure in 2019 1
1 Source: Marketresearch.com
Digital
Health
Market size in 2020
Growing at ~40% year-on-year
2
2 Source: McKinsey Insights
Insurer Dynamics| claims per annum GP clinics
major hospitals
Asia healthcare expenditure within the next 10 years
in markets where AIA operate

-- 67 of 72 --

68
Ping An Health
PAH’s operating
results pre-tax
to R1.1bn
(DSY’s share is R277m)
New business1
to R5.7bn
Written premium1
to R20.4bn
1 100% of PAH
Discovery’s operating
result after tax
to R140m
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
Own Licence Reinsurance
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
Growth in
Own Licence
business
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022

-- 68 of 72 --

69
Exceptional calendar year growth, focused on sustainable growth
reflected through high-quality business metrics
-500
0
500
1,000
1,500
2,000
2,500
3,000
3,500
2017 2018 2019 2020 2021
Jan-June July-Dec
Operating result grew 44%
over CY2021
Calendar
year growth
PAH operating result pre-tax ZARm
High quality metrics and balance sheet
strength
Absolute improvement since prior
period in Combined Operating Ratio
Figures shown for CY2021
1 Incudes reinsurance lives 2 Chinese Life Insurers Ranking Q3 2021
Profit ranking out of 80
insurers1
Market share2
PAH is one of the
most profitable
insurers in China
Return on equity
Solvency Ratio
(as at 31 Dec 2021)
Net profit margin
(19% improvement since prior period)
Net Asset Value
(26% growth from prior period)
Lapse rates
Lives1
Dec-19 Jun-20 Dec-20 Jun-21 Dec-21
-3.1%

-- 69 of 72 --

70
2019 2020 2021
Distribution channels are being optimised to adapt to a maturing
business model, balancing both scale and quality
Historic business model
prioritised scale to establish
market position
Beijing
Hebe
i
Tianji
n	
Jiangsu
Shanghai
(HQs)	
Zheijian
g
Sichuan
Guangdong
Shenzhen
Hen
an
Hubei
Liaoni
ng
Chongqi
ng
Shandong
Fujian
Hunan
PAH licensed regions
PAH unlicensed regions
PAH licensed regions represent
58% of GDP1
Maturing business model leverages capabilities
to create customers value
Optimise distribution
channels to own
customers
Selectively expand
PAG collaboration to
reach targeted
customer segments
Areas with an
insurance license
Control 100% of
business
Customer
access
Higher
profitability
Control expenses,
commissions and
pricing
Opportunity
identified
Leverage insurance
capabilities to
generate revenue
and profits
Ability to
manage risk
Directly manage
underwriting, pricing
& risk management
Continue branch
expansion and grow
own license business
Change in
Combined
Operating Ratio
-3.7%
1 Source: China statistical yearbook 2021 edition
Reaching customers through
new and diverse channels
Dec-20 Dec-21
Group channel Others
SuiShenYi Non-PAL Cross selling
PAL individual channel
28% 44%
New business split through own
license channels
Development of new channels
Ping An Bank
Holistic bank providing
retail, corporate, and
banking technology
services to clients
across China
Ping An Puhui
A leading technology-
powered platform,
providing access to
financing for small
and micro enterprises

-- 70 of 72 --

71
Three concurrent areas of focus
Navigating
COVID-19
Drive
for
growth
Robust
performance
with capital and
liquidity
strength

-- 71 of 72 --

UNAUDITED
INTERIM RESULTS
for the six months ended 31 December 2021

-- 72 of 72 --